Phibro Animal Health Corporation (PAHC)
Price:
54.59 USD
( - -0.11 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Esperion Therapeutics, Inc.
VALUE SCORE:
5
2nd position
Amphastar Pharmaceuticals, Inc.
VALUE SCORE:
11
The best
ANI Pharmaceuticals, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
NEWS
Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell?
fool.com
2026-02-27 13:56:43CEO Jack Bendheim sold 14,080 shares indirectly through BFI Co. LLC over multiple dates for proceeds of ~$728,000 at an average price around $51.68 per share. The transaction represented 20.83% of Mr.
4 Low-PEG Value Stocks for Smarter Portfolio Growth Today
zacks.com
2026-02-26 15:01:09CROX joins three other low-PEG stocks screening for growth, liquidity and value metrics to help investors sidestep potential traps.
Phibro Animal Health Corporation (PAHC) Presents at BofA Securities Animal Health Summit Transcript
seekingalpha.com
2026-02-26 14:17:49Phibro Animal Health Corporation (PAHC) Presents at BofA Securities Animal Health Summit Transcript
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
zacks.com
2026-02-23 09:01:15Top-ranked stocks Revolve Group (RVLV), Phibro Animal Health (PAHC), Silicon Motion Technology (SIMO) and IPG Photonics (IPGP) are likely to beat on the bottom line in their upcoming releases.
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance
fool.com
2026-02-22 02:08:29This animal health company recently had a strong earnings report, and shortly after, its President and CEO sold thousands of shares.
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of “Hold” by Analysts
defenseworld.net
2026-02-21 04:10:47Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to
Best Momentum Stocks to Buy for February 20th
zacks.com
2026-02-20 11:01:10PAHC, CRZBY and WTI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 20th, 2026.
New Strong Buy Stocks for February 20th
zacks.com
2026-02-20 08:20:33WTBA, NABZY, PAHC, CRZBY and HLF have been added to the Zacks Rank #1 (Strong Buy) List on February 20th, 2026.
Best Value Stocks to Buy for February 20th
zacks.com
2026-02-20 08:20:30HLF and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 20th, 2026.
Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit
businesswire.com
2026-02-18 16:30:00TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit. Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors on Thursday, February 26, 2026, at 10:45 AM ET. The live audio presentation will be available on the Phibro Animal Healt.
4 Discounted PEG Value Stocks to Boost Your Portfolio's Health
zacks.com
2026-02-10 10:35:27Discounted PEG screen highlights four value stocks, led by healthcare. One can pick Exelixis, alongside DaVita, Phibro and Allison Transmission.
3 Reasons Growth Investors Will Love Phibro (PAHC)
zacks.com
2026-02-06 13:45:27Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com
2026-02-06 10:51:14Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Phibro Animal Health (NASDAQ:PAHC) Hits New 12-Month High After Earnings Beat
defenseworld.net
2026-02-06 01:56:55Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) shares reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $48.66 and last traded at $47.4450, with a volume of 139415 shares. The stock had previously closed at $41.00. The company reported $0.87
Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript
seekingalpha.com
2026-02-05 15:54:26Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
businesswire.com
2026-02-04 16:25:00TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Dil.
Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell?
fool.com
2026-02-27 13:56:43CEO Jack Bendheim sold 14,080 shares indirectly through BFI Co. LLC over multiple dates for proceeds of ~$728,000 at an average price around $51.68 per share. The transaction represented 20.83% of Mr.
4 Low-PEG Value Stocks for Smarter Portfolio Growth Today
zacks.com
2026-02-26 15:01:09CROX joins three other low-PEG stocks screening for growth, liquidity and value metrics to help investors sidestep potential traps.
Phibro Animal Health Corporation (PAHC) Presents at BofA Securities Animal Health Summit Transcript
seekingalpha.com
2026-02-26 14:17:49Phibro Animal Health Corporation (PAHC) Presents at BofA Securities Animal Health Summit Transcript
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
zacks.com
2026-02-23 09:01:15Top-ranked stocks Revolve Group (RVLV), Phibro Animal Health (PAHC), Silicon Motion Technology (SIMO) and IPG Photonics (IPGP) are likely to beat on the bottom line in their upcoming releases.
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance
fool.com
2026-02-22 02:08:29This animal health company recently had a strong earnings report, and shortly after, its President and CEO sold thousands of shares.
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of “Hold” by Analysts
defenseworld.net
2026-02-21 04:10:47Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to
Best Momentum Stocks to Buy for February 20th
zacks.com
2026-02-20 11:01:10PAHC, CRZBY and WTI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 20th, 2026.
New Strong Buy Stocks for February 20th
zacks.com
2026-02-20 08:20:33WTBA, NABZY, PAHC, CRZBY and HLF have been added to the Zacks Rank #1 (Strong Buy) List on February 20th, 2026.
Best Value Stocks to Buy for February 20th
zacks.com
2026-02-20 08:20:30HLF and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 20th, 2026.
Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit
businesswire.com
2026-02-18 16:30:00TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit. Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors on Thursday, February 26, 2026, at 10:45 AM ET. The live audio presentation will be available on the Phibro Animal Healt.
4 Discounted PEG Value Stocks to Boost Your Portfolio's Health
zacks.com
2026-02-10 10:35:27Discounted PEG screen highlights four value stocks, led by healthcare. One can pick Exelixis, alongside DaVita, Phibro and Allison Transmission.
3 Reasons Growth Investors Will Love Phibro (PAHC)
zacks.com
2026-02-06 13:45:27Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com
2026-02-06 10:51:14Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Phibro Animal Health (NASDAQ:PAHC) Hits New 12-Month High After Earnings Beat
defenseworld.net
2026-02-06 01:56:55Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) shares reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $48.66 and last traded at $47.4450, with a volume of 139415 shares. The stock had previously closed at $41.00. The company reported $0.87
Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript
seekingalpha.com
2026-02-05 15:54:26Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
businesswire.com
2026-02-04 16:25:00TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Dil.